Back to search
FDAFDA · Food and drugs·Recall number Z-0386-2013

Trilogy II Constrained Liner The Trilogy Longevity Constrained Liner serves as the articular surface for a femoral head in total hip arthroplasty.

Published November 28, 2012 · Recall initiated: August 27, 2012

Summary

FDA records medical device Class II recall Z-0386-2013, published November 28, 2012 and initiated August 27, 2012. Recalling firm: Zimmer, Inc.; Status: Terminated; Reported quantity: 1; Lot: Item 00-6334-062-36, Lot 62023769. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Trilogy Longevity Constrained Liner devices were packaged in incorrect cartons. The product is packaged in the incorrect carton. Product labels and patient labels are correct, matching the product inside the carton.

What to do

Voluntary: Firm initiated · Telephone

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Zimmer, Inc.
Distributor
USA (nationwide) including the states of Ohio, Carolinas and New England.
Lot
Item 00-6334-062-36, Lot 62023769
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Trilogy II Constrained Liner The Trilogy Longevity Constrained Liner serves as the articular surface for a femoral head in total hip arthroplasty. recalled?

Yes. FDA published recall Z-0386-2013 on November 28, 2012. Reported hazard: Trilogy Longevity Constrained Liner devices were packaged in incorrect cartons. The product is packaged in the incorrect carton. Product labels and patient labels are correct, matching the product inside the carton.

What should I do if I have this product?

Voluntary: Firm initiated · Telephone